Entekor -1 (30 Tablets)

Entecavir Tablets IP 1 mg

Enquire NOW!




Description

Description

Entekor – 1mg

Composition: Entecavir – 1mg

Therapeutic class: Antiviral

Entekor: Doctor’s Prescribed Hepatitis B Medicine

Entekor is available worldwide in 50+ countries and is the accepted brand for affordable, high-quality treatments.

Aprazer Healthcare: Pioneering Hepatology Care Medicines

Aprazer Healthcare, the leading hepatology medicine manufacturer, develops high-quality, world-standard medicines.

  • • WHO-GMP certified, Assured Therapeutic efficacy and safety.
  • • All the WHO-listed essential hepatitis medicines are manufactured and supplied globally at the most affordable range.

What is Entekor?

Entekor is an antiviral drug that mimics the natural nucleoside, widely used in treating Hepatitis B.

How does Entekor work?

It enters viral DNA, inhibits polymerase, halting chain elongation and propagation.

Uses of Entekor

  • • It is used in Chronic Hepatitis B
  • • Preventive care to prevent the recurrence of Hepatitis B

Benefits

  • • Suppress viral load
  • • Can be used after a liver transplant
  • • Can be used in HIV co-infection
  • • In advanced liver disorders

Common Side Effects

Nausea, dizziness, headache, digestive issues, tiredness, diarrhea

Serious Side Effects

  • Lactic acidosis –lactic acid buildup in blood, causing muscle pain, unusual tiredness.
  • • Enlarged fatty liver
  • • Hepatitis B flare-ups
  • • HIV co-infection may worsen
  • • Renal dysfunctions

Precautions

  • • Kidney disorder
  • • Liver dysfunction
  • • Liver transplant
  • • HIV co-infection
  • • Pediatric function
  • • Elderly patient

Contraindications

  • • Not to be used if any previous allergy or hypersensitivity to Entacavir or any excipients.
  • • Breastfeeding mothers
  • • Pregnant women

Warning

To be used under medical prescription only

Important Safety and Monitoring Information

  • • Regular monitoring of the liver function, renal function, and bone density.
  • • Screen for viral load and HIV infections before treatment initiation.
Download Product PDF Attachment